APIS/LEVISTICUM II ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Apis/Levisticum II, liquid dilution for injection. Indications: In accordance with anthroposophical knowledge of man and nature. These include: Harmonization of the interaction between the ego and sensory organization in acute inflammatory, painful diseases of the nervous-sensory system as well as the metabolic-motor system, e.g. nerve inflammation (neuritis), nerve pain (neuralgia), muscle pain (myalgia), middle ear inflammation (otitis media).

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Apis/Levisticum II, liquid dilution for injection

Composition
1 ampoule contains: Apis mellifica ex animale toto GI Dil. D4 0.1 g (HAB, Vs. 41c), Levisticum officinale e radice ferm 33c Dil. D3 0.1 g (HAB, Vs. 33c). Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Indications:
According to anthroposophical understanding of man and nature. These include: Harmonization of the interaction of the ego and sensory organization in acute inflammatory, painful diseases of the nervous-sensory system as well as the metabolic-motor system, e.g., nerve inflammation (neuritis), nerve pain (neuralgia), muscle pain (myalgia), middle ear inflammation (otitis media).

Contraindications:
Do not use in cases of known hypersensitivity to bee venom.

Precautions for use and warnings:
In the presence of a bee venom allergy, administration of this medication may lead to allergic reactions, which may include hives (urticaria), shortness of breath (bronchospasticity), and, in extreme cases, anaphylactic shock with cardiac arrest. Although severe allergic reactions following administration of the drug have not been reported despite decades of use, they cannot be ruled out. The risk of such reactions is likely to be increased if the drug is accidentally injected into a vein. The instructions for injection technique provided under "Dosage and Method of Administration" should therefore be carefully followed. If skin itching, shortness of breath, dizziness, or other worrying symptoms occur during or after administration, the injection should be discontinued and a doctor should be contacted immediately. It is recommended that the patient be placed in a flat position, elevating the legs if necessary.

Dosage and Method of Administration:
Unless otherwise prescribed:

• Children under 6 years of age: Inject 0.5 ml subcutaneously 2 times weekly to 1 time daily.
• Children aged 6 to under 12 years: Inject 0.5 to 1 ml subcutaneously 2 times a week to 1 time a day.
• Adults and children 12 years and older: Inject 1 ml subcutaneously or intramuscularly 2 times a week to 1 time a day.

Duration of use:
Treatment of an acute illness should be completed after 2 weeks. If no improvement occurs within 2 days, consult a doctor. If longer treatment is necessary, please discuss this with your doctor.

Side effects:
Harmless redness may occur around the injection site during the injection.

Contents:
10 x 1 ml.

Pharmaceutical company and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1,
73087 Bad Boll/Eckwälden.

This leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of March 2025.

Areas of application: According to anthroposophical understanding of man and nature. These include: Harmonization of the interaction of the ego and sensory organization in acute inflammatory, painful diseases of the nervous-sensory system and the metabolic-motor system, e.g., nerve inflammation (neuritis), nerve pain (neuralgia), muscle pain (myalgia), and middle ear infections (otitis media).